Bleeding is infrequent in patients with Factor X levels above 20%, while patients with FX levels < 10% present with mucocutaneous bleeding and those with moderate–severe deficiency may have symptoms, including hemarthrosis, intracranial hemorrhage, and gastrointestinal bleeding. This evidence concerns the gene F10 and hemarthrosis.